Latest / Dementia Researcher Blogs
Dr Kamar Ameen-Ali - Addressing inequalities in access to dementia treatment
Dr Kamar Ameen-Ali narrates her blog written for Dementia Researcher.
In this blog Kamar discusses the inequalities in access to new Alzheimer's disease treatments following the UK approval of lecanemab and donanemab in 2024. Although these drugs were hailed as a breakthrough, they were not recommended for NHS use due to their high cost, limited efficacy, and safety concerns, meaning only those who can afford private treatment will benefit. This decision disproportionately affects lower socioeconomic groups, who are already at greater risk of developing dementia - not to mention others in low…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.